Ultomiris SC QW (ravulizumab-cwvz SC) / AstraZeneca 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ultomiris SC QW (ravulizumab-cwvz SC) / AstraZeneca
NCT03748823 / 2017-002370-39: Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Completed
3
139
Europe, Canada, US, RoW
Ravulizumab OBDS, Ravulizumab, ALXN1210
Alexion Pharmaceuticals, Inc.
Paroxysmal Nocturnal Hemoglobinuria
02/21
08/23

Download Options